Search

Search Constraints

You searched for: Author/Creator Olschewski, Martin

Search Results

5. The FDA approved PI3K inhibitor GDC‐0941 enhances in vitro the anti‐neoplastic efficacy of Axitinib against c‐myc‐amplified high‐risk medulloblastoma. Issue 4 (29th January 2018)